Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jibo Han

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 10, 2018
Inhibition of Epidermal Growth Factor Receptor (EGFR) Reduces Lipopolysaccharide (LPS)-Induced Activation and Inflammatory Cytokines in Hepatic Stellate Cells In VitroYuanyuan Qian, Jibo Han, Liqin Zhou, et al.
International Immunopharmacology|July 17, 2024
Schisandrin B alleviates angiotensin II-induced cardiac inflammatory remodeling by inhibiting the recruitment of MyD88 to TLRs in mouse cardiomyocytesSujing Xu, Chenghong Hu, Jibo Han, et al.
Heliyon|June 12, 2023
Gasdermin D affects aortic vascular smooth muscle cell pyroptosis and Ang II-induced vascular remodelingZimin Fang, Gaojun Wu, Jian Sheng, et al.
Scientific Reports|March 22, 2017
Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)Zheng Xu, Weixin Li, Jibo Han, et al.
Scientific Reports|July 30, 2021
Author Correction: Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)Zheng Xu, Weixin Li, Jibo Han, et al.
Obesity (Silver Spring, Md.)|July 21, 2017
MD2 Blockage Protects Obesity-Induced Vascular Remodeling via Activating AMPK/Nrf2Lintao Wang, Jibo Han, Peiren Shan, et al.
Endocrine|February 3, 2018
Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stressXuemei Chen, Jianchang Qian, Lintao Wang, et al.
Cell Death and Differentiation|November 8, 2025
USP13 ameliorates diabetic cardiomyopathy via deubiquitinating NLRP3 and inhibiting pyroptosis in cardiomyocytesDiyun Xu, Jibo Han, Bozhi Ye, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 30, 2022
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88-Dependent InflammationWu Luo, Ke Lin, Junyi Hua, et al.
Acta Pharmaceutica Sinica. B|June 9, 2025
Deubiquitinase USP13 alleviates doxorubicin-induced cardiotoxicity through promoting the autophagy-mediated degradation of STINGLiming Lin, Jibo Han, Diyun Xu, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 10, 2018
Inhibition of Epidermal Growth Factor Receptor (EGFR) Reduces Lipopolysaccharide (LPS)-Induced Activation and Inflammatory Cytokines in Hepatic Stellate Cells In VitroYuanyuan Qian, Jibo Han, Liqin Zhou, et al.
International Immunopharmacology|July 17, 2024
Schisandrin B alleviates angiotensin II-induced cardiac inflammatory remodeling by inhibiting the recruitment of MyD88 to TLRs in mouse cardiomyocytesSujing Xu, Chenghong Hu, Jibo Han, et al.
Heliyon|June 12, 2023
Gasdermin D affects aortic vascular smooth muscle cell pyroptosis and Ang II-induced vascular remodelingZimin Fang, Gaojun Wu, Jian Sheng, et al.
Scientific Reports|March 22, 2017
Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)Zheng Xu, Weixin Li, Jibo Han, et al.
Scientific Reports|July 30, 2021
Author Correction: Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)Zheng Xu, Weixin Li, Jibo Han, et al.
Obesity (Silver Spring, Md.)|July 21, 2017
MD2 Blockage Protects Obesity-Induced Vascular Remodeling via Activating AMPK/Nrf2Lintao Wang, Jibo Han, Peiren Shan, et al.
Endocrine|February 3, 2018
Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stressXuemei Chen, Jianchang Qian, Lintao Wang, et al.
Cell Death and Differentiation|November 8, 2025
USP13 ameliorates diabetic cardiomyopathy via deubiquitinating NLRP3 and inhibiting pyroptosis in cardiomyocytesDiyun Xu, Jibo Han, Bozhi Ye, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 30, 2022
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88-Dependent InflammationWu Luo, Ke Lin, Junyi Hua, et al.
Acta Pharmaceutica Sinica. B|June 9, 2025
Deubiquitinase USP13 alleviates doxorubicin-induced cardiotoxicity through promoting the autophagy-mediated degradation of STINGLiming Lin, Jibo Han, Diyun Xu, et al.
Pageof 7